The Cheapest Way to Get Mounjaro: 6 Real Options, Ranked

The cheapest ways to get Mounjaro, one by one

The same drug can cost $25 or more than $1,000 a month. Here is each real option, from cheapest to most expensive, and who it fits.

1. Lilly Savings Card: $25 if your plan covers Mounjaro

This is the end of the search for some women. Your commercial plan must already cover Mounjaro, and your prescription must be for type 2 diabetes. Then a fill can cost $25, for one to three months of medicine.

Lilly pays up to $150 a month of your share and up to $1,950 a year. Medicare, Medicaid, TRICARE and other government plans can't use the card. It ends December 31, 2026. Our Mounjaro savings card guide shows how to activate it.

2. Medicare Part D: often $50 or less for type 2 diabetes

Many Part D drug plans cover Mounjaro for type 2 diabetes. Lilly says about 8 in 10 Part D patients pay $0 to $50 for a 28-day supply. In 2026, your yearly out-of-pocket drug costs stop at $2,100. The savings card is closed to Medicare.

3. Compounded tirzepatide: from about $170 a month, no insurance

Compounded tirzepatide has the same active ingredient, but a pharmacy mixes it and it is not FDA-approved. It needs no insurance.

Mochi Health costs about $170 a month at the lowest dose, including its $79 membership. The price climbs with your dose, up to about $280. New members pay about $90 for the first month, in most states. Prepaying a year of membership brings the lowest dose to about $140 a month.

Curex charges no membership, and its price includes the medicine, the online visit and shipping. Its "from $199" price needs a year paid upfront, at the lowest dose. Month to month, it costs about $250 for a tablet and about $300 for a shot at the starting dose. Higher doses cost about $100 more.

4. Zepbound self-pay: brand-name tirzepatide from about $300

Zepbound is Mounjaro's sister brand. It is the same drug, from the same company, approved for weight loss instead of diabetes. Lilly sells it for cash at a lower price than Mounjaro.

• 2.5 mg: about $300 a month
• 5 mg: about $400 a month
• 7.5 mg to 15 mg: about $450 a month, if you refill within 45 days

Miss the 45-day window and the price is about $500 at 7.5 mg, or about $700 from 10 mg. You can buy the KwikPen at LillyDirect or a local pharmacy, or vials from LillyDirect. Zepbound needs a weight-loss prescription. Lilly's offer ends December 31, 2026.

5. Mounjaro self-pay: about $500 at every dose

Lilly sells Mounjaro itself through LillyDirect from $499 a month, the same at every dose from 2.5 mg to 15 mg. It is open if you have no insurance, or if your plan won't cover Mounjaro. You need a prescription.

If your work plan simply won't cover Mounjaro, the savings card gives the same $499 price. Either way, Zepbound costs less at every dose, if your prescriber agrees it fits.

6. Retail or GoodRx: about $1,100, the price to avoid

Lilly's list price is about $1,110 for a 28-day carton of four pens, at any dose. A GoodRx coupon barely moves it, to about $1,090. Some pharmacies charge more than list without a coupon. Even at the best quote, this costs more than double Lilly's own self-pay price.

Weight loss, not diabetes? Why Zepbound is the cheaper brand

Most people looking for cheap tirzepatide want it for weight loss. For them, the Mounjaro savings card doesn't apply, because Lilly's terms require a prescription for an approved use, and every Mounjaro use is tied to type 2 diabetes.

Zepbound has the weight-loss approval, its own savings card and lower self-pay prices. Ask your prescriber about it. See Mounjaro without insurance for every cash option by situation.

Why insurance denies Mounjaro, and what to do

Plans usually cover Mounjaro for type 2 diabetes and refuse it for weight loss alone. If you do have type 2 diabetes and were denied, ask your prescriber to check what the claim said. Many plans also want a prior authorization, meaning approval before the first fill.

If the plan still says no, you can appeal. Ask your prescriber for a letter that explains your medical need.

Is compounded tirzepatide legal?

Yes, but on a narrower basis than before. The FDA's tirzepatide shortage ended in December 2024. After that, large-scale copies had to stop.

What remains is the 503A route. A state-licensed pharmacy mixes tirzepatide for one named patient. The prescriber must note a real medical reason the brand doesn't fit, such as an allergy to an ingredient. Price alone is not a medical reason.

On April 30, 2026, the FDA proposed not to add tirzepatide, semaglutide and liraglutide to the 503B bulk drug substances list. That list is for large outsourcing facilities. The comment period, extended once, closed on July 30, 2026, with no final decision yet. It doesn't change the 503A route.

Some sellers are also in court. Lilly sued four telehealth companies in April 2025 over how they marketed compounded tirzepatide. A judge threw out the case against Willow in February 2026, and Lilly has appealed. Lilly's cases against Mochi Health and Henry Meds are still open, with jury trials set for January 2028 and October 2027. The compounded Mounjaro guide compares more sellers.

Can you get Mounjaro completely free?

Not from Lilly right now. Lilly Cares, Lilly's charity that gives free medicine to some people with low incomes, does not list Mounjaro or Zepbound.

If you have type 2 diabetes and no coverage, its list does include Trulicity, an older weekly shot. Ask your doctor whether it fits you.

What a full year costs, option by option

Brand-name pens come in 28-day cartons, so a year means 13 fills.

• Lilly Savings Card, plan covers Mounjaro: about $325 a year.
• Medicare Part D: your plan's copays, capped at $2,100 for 2026.
• Mochi Health, month to month: about $1,950 a year at the lowest dose, up to about $3,260 at the top dose.
• Mochi Health, prepaid year of membership: about $1,670 to $2,980 a year.
• Curex: about $2,390 for a year paid upfront at the lowest dose, about $3,590 at higher doses.
• Zepbound self-pay: about $5,100 to $5,650 for the first year, with on-time refills.
• Mounjaro self-pay: about $6,500 a year.
• Retail or GoodRx: about $14,170 to $14,460 a year.

Lilly's card and self-pay offers end December 31, 2026, so 2027 totals depend on Lilly's next prices. The real savings come from knowing which option you qualify for, not from hunting coupons.

Red flags when chasing the cheapest tirzepatide

• A seller that needs no prescription or medical review. That's illegal, and it risks fake products and dosing errors.
• A seller that won't name the licensed pharmacy filling your order. The FDA has found fake compounded tirzepatide whose labels name pharmacies that don't exist.
• "Research use only" or "not for human consumption" on the label.
• A price far below every figure on this page, with no explanation.
• A seller that presents saving money as the medical reason for compounding.